145mg/30粒/盒 适应症 本品在体内经酯酶的作用迅速代谢成非诺贝特酸而起降血脂作用,具有明显的降低血清胆固醇,甘油三酯和升高高密度脂蛋白的作用。 用法用量 成人口服:一次100mg,一日3次。维持量:待血脂明显下降后改为一次100mg。 生产企业 美国Acadia
通用名称:非诺贝特 fenofibrate Lipanthyl 药品规格:145mg/30粒/盒 生产企业:美国Acadia 功能主治: 本品在体内经酯酶的作用迅速代谢成非诺贝特酸而起降血脂作用,具有明显的降低血清胆固醇,甘油三酯和升高高密度脂蛋白的作用 成人口服:一次100mg,一日3次。维持量:待血脂明显下降后改为一次100mg。
药品商标名 Fenofibrate 药品通用名 非诺贝特 活性成分 非诺贝特 药品剂型 片剂 给药途径 口服给药 药品规格 145 规格单位 mg/1 市场分类 仿制药 药品申请号 ANDA205118 标签持有者 Aurobindo Pharma Limited 批准日期 2016-05-05 ATC分类 Peroxisome Proliferator Receptor alpha Agonist [EPC] ...
Brands / Trade Names of Fenofibrate Click on the desired strength of the dosage form to view its available brands. Single Ingredient Tabs: 48 mg, 54 mg, 67 mg, 145 mg, 160 mg, Caps: 67 mg, 134 mg, 200 mg, Multi ingredient Caps: 200 mg, ...
Sauron R, Wilkins M, Jessent V, et al. Absence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulation. Int J Clin Pharmacol Ther 2006 Feb; 44 (2): 64–70 PubMedCASGoogle Scholar Fournier Pharmaceuticals Ltd. Lipantil® Micro 67: summary of product characteristics [...
fenofibrate145mgtablets fenofibrate200mgcap orderfenofibrateonline genericfenofibrate134mg fenofibrate200mgobatapa fenofibratelipanthylnt purchasetricor lipanthyl145mgfenofibrate tricorpricecostco medicaltricorderbuy fungsifenofibrate300mg fenofibrate134mgenespanol ...
Tricor: 48 mg orally once a day. Increases in dosage should occur only after evaluating the effects on renal function and lipid levels at this dose, with a maximum recommended dose of 145 mg/24 hours. Lofibra and others: 54 mg to 67 mg orally once a day with food. Individualize dosage...
Fenofibrate is a fibric acid derivative indicated for the treatment of severe hypertriglyceridaemia and mixed dyslipidaemia in patients who have not respon
Concomitant administration of a single dose of fenofibrate (equivalent to 145 mg fenofibrate) and a single dose of fluvastatin (40 mg) resulted in a small increase (approximately 15% to 16%) in exposure to (+)3R,5S-fluvastatin, the active enantiomer of fluvastatin. A single dose of either...
Alembic Pharmaceuticals receives USFDA Approval for Fenofibrate Tablets USP, 48 mg and 145 mg The study also aimed to develop a method for preparation of an inclusion complex of fenofibrate with HP[beta]CD that is efficient and economical, simple, and less time consuming than other methods. Enha...